Allarity Therapeutics, Inc.
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
ALLR | US
Overview
Corporate Details
- ISIN(s):
- US0167445008
- LEI:
- Country:
- United States of America
- Address:
- 24 SCHOOL ST., 2ND FLOOR, 2108 BOSTON
- Website:
- https://allarity.com/
- Sector:
- Manufacturing
Description
Allarity Therapeutics is a clinical-stage biopharmaceutical company specializing in precision medicine for oncology. The company utilizes its proprietary Drug Response Predictor (DRP®) companion diagnostic platform to identify patients who are most likely to benefit from its targeted cancer therapies. This approach aims to personalize treatment and improve clinical outcomes. Allarity is advancing a pipeline of in-licensed oncology therapeutics, with its lead candidate being stenoparib, a novel, orally available PARP/tankyrase inhibitor. Stenoparib is primarily being developed for the treatment of advanced ovarian cancer. The company focuses on addressing significant unmet medical needs through its targeted therapeutic development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Allarity Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Allarity Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Allarity Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
